Other studies have reported thalamic atrophy in FTD patients (Cardenas et al., 2007; Chow et al., 2008; Garibotto et al., 2011; Hornberger et al., 2012), and in particular in those with TDP-43 pathology (Rohrer et al., 2010b), although a recent voxel-based morphometry study found thalamic involvement in both TDP-43 and tau-associated FTD cases (Harper et al., 2017). The gene discussed is MAPT; the disease is frontotemporal dementia.